- Home
- FULT vs SUPN Comparison
FULT vs SUPN Comparison
Compare FULT & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FULT | SUPN |
|---|---|---|
| Founded | 1882 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.1B |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | FULT | SUPN |
|---|---|---|
| Price | $19.71 | $50.49 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $21.40 | ★ $61.60 |
| AVG Volume (30 Days) | ★ 1.7M | 723.2K |
| Earning Date | 01-01-0001 | 05-21-2026 |
| Dividend Yield | ★ 3.81% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $392,755,000.00 |
| Revenue This Year | $9.75 | $23.19 |
| Revenue Next Year | $5.56 | $17.65 |
| P/E Ratio | $10.58 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.33 | $29.16 |
| 52 Week High | $22.99 | $59.68 |
Technical Indicators
Market Signals| Indicator | FULT | SUPN |
|---|---|---|
| Relative Strength Index (RSI) | 36.12 | 42.91 |
| Support Level | $19.15 | $47.95 |
| Resistance Level | $19.97 | $52.14 |
| Average True Range (ATR) | 0.65 | 2.37 |
| MACD | -0.21 | -0.36 |
| Stochastic Oscillator | 12.38 | 11.04 |
Price Performance
Historical ComparisonAbout FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.